Neumora Therapeutics Statistics

Total Valuation

NMRA has a market cap or net worth of $337.97 million. The enterprise value is $212.28 million.

Market Cap	337.97M
Enterprise Value	212.28M

Important Dates

The last earnings date was Thursday, May 7, 2026, before market open.

Earnings Date	May 7, 2026
Ex-Dividend Date	n/a

Share Statistics

NMRA has 182.69 million shares outstanding. The number of shares has increased by 4.83% in one year.

Current Share Class	182.69M
Shares Outstanding	182.69M
Shares Change (YoY)	+4.83%
Shares Change (QoQ)	+6.74%
Owned by Insiders (%)	4.53%
Owned by Institutions (%)	38.56%
Float	105.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.12
P/TBV Ratio	3.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.53
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-42.99

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-70.23%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	19.11%
Revenue Per Employee	n/a
Profits Per Employee	-$2.32M
Employee Count	96
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NMRA has paid $55,000 in taxes.

Income Tax	55,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +173.65% in the last 52 weeks. The beta is 3.05, so NMRA's price volatility has been higher than the market average.

Beta (5Y)	3.05
52-Week Price Change	+173.65%
50-Day Moving Average	2.14
200-Day Moving Average	2.19
Relative Strength Index (RSI)	43.13
Average Volume (20 Days)	1,429,072

Short Selling Information

The latest short interest is 4.60 million, so 2.52% of the outstanding shares have been sold short.

Short Interest	4.60M
Short Previous Month	4.47M
Short % of Shares Out	2.52%
Short % of Float	4.37%
Short Ratio (days to cover)	3.78

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-218.08M
Pretax Income	-222.34M
Net Income	-222.39M
EBITDA	-217.98M
EBIT	-218.08M
Earnings Per Share (EPS)	-$1.33

Full Income Statement

Balance Sheet

The company has $182.53 million in cash and $55.01 million in debt, with a net cash position of $127.52 million or $0.70 per share.

Cash & Cash Equivalents	182.53M
Total Debt	55.01M
Net Cash	127.52M
Net Cash Per Share	$0.70
Equity (Book Value)	103.87M
Book Value Per Share	0.60
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	103,000
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NMRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.83%
Shareholder Yield	-4.83%
Earnings Yield	-65.45%
FCF Yield	n/a

Analyst Forecast

The average price target for NMRA is $8.91, which is 381.62% higher than the current price. The consensus rating is "Buy".

Price Target	$8.91
Price Target Difference	381.62%
Analyst Consensus	Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a